Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Summit Therapeutics (SMMT) Revenue: 2016-2024

Historic Revenue for Summit Therapeutics (SMMT) over the last 5 years, with Dec 2024 value amounting to -$9,000.

  • Summit Therapeutics' Revenue was N/A to -$9,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$8.7 million, marking a year-over-year change of. This contributed to the annual value of -$8.7 million for FY2024, which is 43.82% up from last year.
  • According to the latest figures from Q4 2024, Summit Therapeutics' Revenue is -$9,000, which was up 99.63% from -$2.5 million recorded in Q3 2024.
  • In the past 5 years, Summit Therapeutics' Revenue ranged from a high of $324,312 in Q1 2020 and a low of -$3.1 million during Q1 2024.
  • In the last 2 years, Summit Therapeutics' Revenue had a median value of -$2.5 million in 2024 and averaged -$1.7 million.
  • Data for Summit Therapeutics' Revenue shows a maximum YoY crashed of 33.57% (in 2020) over the last 5 years.
  • Over the past 3 years, Summit Therapeutics' Revenue (Quarterly) stood at $324,312 in 2020, then followed by $220,000 in 2022, then followed by -$9,000 in 2024.
  • Its Revenue stands at -$9,000 for Q4 2024, versus -$2.5 million for Q3 2024 and -$3.1 million for Q2 2024.